Kenan Turnacioglu

Chairman at

Paige.Ai, Inc.

55 year

9 connections

Finance

Consumer Services

Technology Services

Profile

Kenan Turnacioglu is the founder of PointState Capital LP, which was founded in 2011.
He held the title of Vice Chairman at PointState Capital LP.
He is currently the Chairman at Paige.
Ai, Inc. since 2017.
Dr. Turnacioglu has also held former positions as a Director at Stemcentrx, Inc. from 2013 to 2016, as well as a Director at Agensys, Inc. from 2004 to 2007.
He was also a Director at Immunai, Inc., HealthCor Catalio Acquisition Corp., and Nyu Langone Cancer Center from 2010 to 2015.
Additionally, Dr. Turnacioglu worked as an Equity Analyst at Duquesne Capital Management LLC.
He was a General Partner at Catalio Capital Management LP from 2020 to 2021.
Dr. Turnacioglu obtained a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers State University of New Jersey.

Kenan Turnacioglu active positions

Companies	Position	Start
Paige.Ai, Inc. Paige.Ai, Inc. Packaged SoftwareTechnology Services Operates as an AI company specializing in digital pathology	Chairman	01/01/2017

All active positions of Kenan Turnacioglu

Former positions of Kenan Turnacioglu

Companies	Position	End
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Investment Committee Member	31/10/2021
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Director/Board Member	01/01/2016
Nyu Langone Cancer Center	Director/Board Member	01/01/2015
Duquesne Capital Management LLC Duquesne Capital Management LLC Investment ManagersFinance Duquesne Capital Management is a top-down manager that invests in growth-oriented value stocks. The firm looks for market leaders and turnaround stocks. They focus primarily on investments in the stocks of mid-cap and large-cap US companies in the energy minerals, process industries, health technology and electronic technology sectors. Duquesne Capital Management maintains a very high turnover rate.	Analyst-Equity	31/10/2010
Agensys, Inc. Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers	Director/Board Member	01/01/2007

See the detail of Kenan Turnacioglu's experience

Training of Kenan Turnacioglu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenan Turnacioglu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Duquesne Capital Management LLC Duquesne Capital Management LLC Investment ManagersFinance Duquesne Capital Management is a top-down manager that invests in growth-oriented value stocks. The firm looks for market leaders and turnaround stocks. They focus primarily on investments in the stocks of mid-cap and large-cap US companies in the energy minerals, process industries, health technology and electronic technology sectors. Duquesne Capital Management maintains a very high turnover rate.	Finance
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Agensys, Inc. Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers	Commercial Services
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PointState Capital LP PointState Capital LP Investment ManagersFinance PointState Capital aims to achieve superior capital appreciation by pursuing multiple investment strategies including, but not limited to long/short equities, global macro, investing in commodity and commodity-related industries, high yield and distressed credit, event-driven/special situations investing, relative value investing and private investments.	Finance
Paige.Ai, Inc. Paige.Ai, Inc. Packaged SoftwareTechnology Services Operates as an AI company specializing in digital pathology	Technology Services
Immunai, Inc. Immunai, Inc. Packaged SoftwareTechnology Services Develops immune system technology to treat oncology diseases	Technology Services
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Finance
HealthCor Catalio Acquisition Corp. HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
Nyu Langone Cancer Center